Position in BMY
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$334,772
+$135,457 QoQ
Shares Held
5,810
+77.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#1,800
of 2,506 holders
Holding Since
Jun 2021
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Continuum Advisory, LLC holds $15,181,531 across 16 Drug Manufacturers - General names. BMY ranks #8 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,744 | $5,690,096 | |
| 2 | ABBV |
AbbVie Inc.
|
13,684 | $3,443,441 | |
| 3 | MRK |
Merck & Co., Inc.
|
9,850 | $1,265,725 | |
| 4 | AMGN |
Amgen Inc
|
3,476 | $1,258,729 | |
| 5 | JNJ |
Johnson & Johnson
|
4,515 | $1,146,674 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
5,971 | $754,376 | |
| 7 | PFE |
Pfizer Inc
|
21,218 | $510,929 | |
| 8 | BMY |
Bristol Myers Squibb Co
This page
|
5,810 | $334,772 |
All Filings in BMY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $334,772 | 5,810 | Shares | Sole | 2026-08-06 | |
| 2025-03-31 | $199,315 | 3,268 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $98,018 | 1,733 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $77,920 | 1,506 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $44,976 | 1,083 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $3,402,335 | 62,739 | Shares | Sole | 2024-05-13 | |
| 2021-06-30 | $273,895 | 4,099 | Shares | Sole | 2023-12-13 | |
| No filing history on record for this holder in this stock. | ||||||